Viewing Study NCT01689220


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2025-12-26 @ 3:05 AM
Study NCT ID: NCT01689220
Status: COMPLETED
Last Update Posted: 2014-09-04
First Post: 2012-09-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea
Sponsor: Solasia Pharma K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module